ACTA Constitution

26.11.2020

ACTA Advocacy

Following comprehensive governance and structural reviews, in 2020, ACTA amended the Constitution in order to improve the operational efficiency of the organisation. This was an important step towards one of our key strategies to build a sustainable and well-run organisation.

ACTA Constitution 2020

Type of resource: pdf

ACTA

PDF

Latest Resource

Development of the Consumer Involvement and Engagement Toolkit

Type of resource: This resource is coming from ACTA Topics:Consumer Engagement ACTA Members ACTA
Strengthening the capacity, efficiency and effectiveness of Clinical Trials Networks: Activity Overview 2017–2021

Type of resource: Topics:ACTA
ACTA 2020-2021 Annual Report

Type of resource: ACTA
ACTA Whistleblower Policy

Type of resource: This resource is coming from ACTA Topics:Advocacy
MEDIA RELEASE: ACTA appoints Prof Steve Webb as its new Chair and Ian Wilson as Additional Independent Director

Type of resource: This resource is coming from ACTA Topics:ACTA
Official Opening of the 2020 ACTA Summit: Minister’s Address

Type of resource: This resource is coming from ACTA Topics:Summit ACTA Advocacy
ACTA submission: Parliamentary Inquiry into approval processes for new drugs and novel medical technologies in Australia

This resource is coming from ACTA Topics:Advocacy
Statistical Analysis Plan (SAP)

Type of resource: This resource is coming from ACTA Topics:ACTA Statistics Innovative Trial Design
ACTA Board Charter

Type of resource: This resource is coming from ACTA Topics:ACTA
Media Release: Australian Clinical Trials Alliance commends the Health Minister’s vision to expedite clinical trials in Australia

Type of resource: This resource is coming from ACTA Topics:Advocacy
ACTA Trial of the Year Award 2020 guidelines and nomination forms

Type of resource: Topics:ACTA Advocacy National Tribute & Award Ceremony
ACTA Year in Review: Financial Year 2018-2019

Type of resource: Topics:ACTA Advocacy
ACTA Resources Brochure

Type of resource: Topics:ACTA
ACTA activity work plan 2019 – 2020

Type of resource: Topics:ACTA Advocacy
Report on the activities and achievements of clinical trials networks in Australia 2004 – 2014

Type of resource: Topics:Advocacy ACTA
What a trialist should know about implementation to practice

Type of resource: Topics:ACTA CTN Impact & Implementation
Submission to MRFF Consultation

Type of resource: Topics:ACTA Advocacy
Submission to Medical Research Future Fund Priority Consultation

Type of resource: Topics:Advocacy ACTA
Medical Research Future Fund – clinical trial funding set to deliver significant benefits to Australian patients and the economy

Type of resource: This resource is coming from ACTA Topics:ACTA Advocacy
ACTA Advisory Council minutes July 2017

Type of resource: Topics:ACTA Advocacy
Economic evaluation of investigator-initiated clinical trials conducted by networks

Type of resource: Topics:Advocacy ACTA
Economic evaluation of investigator-initiated clinical trials conducted by networks – Appendix: Individual trial-level results

Type of resource: Topics:ACTA CTN Impact & Implementation
Open letter to the Hon Greg Hunt MP following announcement of MRFF funding for ACTA and clinical trials

Type of resource: Topics:ACTA
Opportunities for linking evidence development to reimbursement in Australia

Type of resource: Topics:Advocacy
Clinical Quality Registries: A national approach

Type of resource: Topics:Advocacy
How can clinical trials networks drive better translation of evidence into better quality care?

Type of resource: Topics:ACTA Advocacy
The Global Perspective: Measuring the impact of Australian-led trials & registries internationally

Type of resource: Topics:ACTA Advocacy
ACTA Summit 2016 – Opening address

Type of resource: Topics:ACTA Advocacy
ACTA Submission to the NHMRC Public Consultation on revisions to sections 3 & 5 of the National Statement

Type of resource: Topics:ACTA Advocacy
ACTA Summit 2016 – Dr Neil Soderlund

Type of resource: Topics:ACTA Advocacy
Medical Research Future Fund set to put high quality evidence at the heart of healthcare – historic moment for all Australians

Type of resource: Topics:ACTA Advocacy
ACTA STInG Submission to the NHMRC Structural Review

Type of resource: Topics:ACTA Statistics
ACTA Submission to the NHMRC Structural Review

Type of resource: Topics:ACTA Advocacy
ACTA Submission on the MRFF Strategy & Priorities

Type of resource: Topics:ACTA Advocacy
ACTA Submission on the National Safety and Quality Health Service Standards Version 2: Consultation Draft

Type of resource: Topics:Advocacy ACTA
ACTA Submission to the Medicare Benefits Schedule Review Taskforce

Type of resource: Topics:ACTA Advocacy

Resource Documents

ACTA Constitution 2020

Latest Resource

Development of the Consumer Involvement and Engagement Toolkit

Strengthening the capacity, efficiency and effectiveness of Clinical Trials Networks: Activity Overview 2017–2021

ACTA 2020-2021 Annual Report

ACTA Whistleblower Policy

MEDIA RELEASE: ACTA appoints Prof Steve Webb as its new Chair and Ian Wilson as Additional Independent Director

Official Opening of the 2020 ACTA Summit: Minister’s Address

ACTA submission: Parliamentary Inquiry into approval processes for new drugs and novel medical technologies in Australia

Statistical Analysis Plan (SAP)

ACTA Board Charter

Media Release: Australian Clinical Trials Alliance commends the Health Minister’s vision to expedite clinical trials in Australia

ACTA Trial of the Year Award 2020 guidelines and nomination forms

ACTA Year in Review: Financial Year 2018-2019

ACTA Resources Brochure

ACTA activity work plan 2019 – 2020

Report on the activities and achievements of clinical trials networks in Australia 2004 – 2014

What a trialist should know about implementation to practice

Submission to MRFF Consultation

Submission to Medical Research Future Fund Priority Consultation

Medical Research Future Fund – clinical trial funding set to deliver significant benefits to Australian patients and the economy

ACTA Advisory Council minutes July 2017

Economic evaluation of investigator-initiated clinical trials conducted by networks

Economic evaluation of investigator-initiated clinical trials conducted by networks – Appendix: Individual trial-level results

Open letter to the Hon Greg Hunt MP following announcement of MRFF funding for ACTA and clinical trials

Opportunities for linking evidence development to reimbursement in Australia

Clinical Quality Registries: A national approach

How can clinical trials networks drive better translation of evidence into better quality care?

The Global Perspective: Measuring the impact of Australian-led trials & registries internationally

ACTA Summit 2016 – Opening address

ACTA Submission to the NHMRC Public Consultation on revisions to sections 3 & 5 of the National Statement

ACTA Summit 2016 – Dr Neil Soderlund

Medical Research Future Fund set to put high quality evidence at the heart of healthcare – historic moment for all Australians

ACTA STInG Submission to the NHMRC Structural Review

ACTA Submission to the NHMRC Structural Review

ACTA Submission on the MRFF Strategy & Priorities

ACTA Submission on the National Safety and Quality Health Service Standards Version 2: Consultation Draft

ACTA Submission to the Medicare Benefits Schedule Review Taskforce